Petitions.com
Browse Petitions Search Contact the petition author Contact Us Languages Manage your signatures Confirm your signature with a code Log in
Start a Petition

Report a petition

Gilead: Please ask Health Canada to approve Truvada for PrEP

Petitions express opinions. Disagreeing with a petition, or thinking it is pointless, is not grounds for a report, and such reports are closed automatically. Report a petition only if it breaks the law or our Community Guidelines, for example hate speech, defamation of a person or organisation, publishing private information, or fraud. We do not check whether the claims in a petition are true; the author is responsible for them.

This report goes to the people who run this website, not to the petition author or to any authority. If you have a question or feedback for the author, send them a message.

Why are you reporting this?
What is wrong with the name?
Please tell us in the text field below what makes you think so.

Petitions express opinions. Disagreeing with a petition, or thinking it is pointless, is not grounds for a report, and we do not remove petitions because people oppose them.

If you send this, your disagreement is recorded and the report is closed automatically with no action; the decision is sent to your email address. If the content breaks the law or our Community Guidelines, choose that option above instead.

You can also start your own petition or contact the author.

Is the false claim about you, your organisation, or another identifiable person or organisation?

Which passage is false? You can click several sentences in the petition text, and tell us for each what is true. This is optional.

Sentences next to each other are joined into one claim. Click a sentence again to remove it.

Gilead: Please ask Health Canada to approve Truvada for PrEP

We are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis (PrEP). If you agree, please sign our Open Letter to Gilead Sciences.

Ed Gudaitis, General Manager

Gilead Sciences Canada

6711 Mississauga Road, Suite 600

Mississauga, ON

L5N 2W3

April 28th, 2015

Dear Mr. Gudaitis:

On behalf of HIV prevention agencies, gay men’s health organizations and gay men in Canada, we are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis.

In December 2010 the New England Journal of Medicine published findings from the Gilead sponsored iPrEx trial examining the effectiveness of HIV pre-exposure prophylaxis (PrEP) in gay men and other men who have sex with men. The study ultimately showed that HIV was successfully prevented in over 90% of cases in men who were adherent to a daily dose of Truvada. Similar results were demonstrated in the subsequent PROUD trial from the UK and IPERGAY in France and Canada.

The advent of PrEP and its subsequent uptake by HIV-negative gay men, particularly in the United States, has been a welcome addition to the HIV prevention toolkit. Traditional interventions such as education, condoms, and treatment as prevention have been highly successful but they have failed to completely stem the tide of new infections. In 2011, the Public Health Agency of Canada estimated the HIV incidence rate for men who have sex with men was 71 times higher than other men. In 2013 approximately 1000 Canadian gay men were diagnosed with HIV. These account for 50% of new infections in the country. Most become infected by partners who themselves are newly infected and/or unaware of their sero-positive status. PrEP offers additional protection to HIV-negative men who may find themselves in these situations.

In July 2012 the FDA approved the use of Truvada for PrEP in the United States and the US Centre for Disease Control developed clinical practice guidelines for administration of PrEP in vulnerable populations. Yet access to Truvada for PrEP in Canada remains elusive. Currently, it is prescribed “off-label” and treatment is administered under a patchwork of monitoring with little or no regulation. We applaud Gilead’s support for PrEP in the United States and its recent announcement to seek approval in Australia but without formal approval in Canada it is not possible to establish publicly funded and regulated programs, or to evaluate cost effectiveness and safety. This leaves gay men and other vulnerable groups with limited access to a proven prevention tool. We find this policy inequitable and harmful to gay men’s health.

At Health Initiative for Men, we consider PrEP to be a safe and effective HIV prevention tool when it is prescribed and administered in a regulated environment. We believe that barriers to access should be minimized for gay men and other vulnerable populations. A formally approved indication for the use of Truvada in HIV pre-exposure prophylaxis is the first step to achieving this goal. We further intend to actively petition public health officials at all levels for comprehensive PrEP guidelines and for approval of publicly funded programs. If we are to be serious about stopping HIV in all populations, and particularly in gay men, we must make PrEP more easily accessible. To quote from Chris Beyrer at the Center for Public Health and Human Rights in a recent Lancet publication, ‘Pre-exposure prophylaxis works – it’s time to deliver’.

Board of Directors,

Health Initiative for Men

Signatories:

AIDS Committee of Toronto (ACT)

AIDS Vancouver

Canadian Association of Nurses in HIV/AIDS Care (CANAC)

CATIE

REZO: Santé et mieux-être des hommes gais et bisexuels

Vancouver Coastal Health Regional HIV Program

YouthCO HIV & Hep C Society

We do not check whether the claims in a petition are true; the author is responsible for them. If you send this, it is recorded and the report is closed automatically with no action; the decision is sent to your email address.

You can start your own petition with the information you believe is correct, or contact the author.

A false claim about an identifiable person or organisation is defamation, and we do act on that.

Continue: report defamation

Who is the content about?
Is the person the content is about a politician, a decision-maker or another public figure?
What does the content criticise?

Public criticism of how a politician or decision-maker acts in a public role is allowed, also when the events are old. That a matter is old is not in itself a ground for removal. We can still act on a false claim about the person or on otherwise unlawful content.

If the matter is old or no longer current, it is best to contact the petition author directly. The author can remove the petition for any reason; we cannot.

Is the person the content is about a politician, a decision-maker or another public figure?
What does the content criticise?

Public criticism of how a politician or decision-maker acts in a public role is allowed, also when the events are old. That a matter is old is not in itself a ground for removal. We can still act on a false claim about the person or on otherwise unlawful content.

If the matter is old or no longer current, it is best to contact the petition author directly. The author can remove the petition for any reason; we cannot.

We do not check whether the claims in a petition are true; the author is responsible for them. We act on a false claim when it concerns an identifiable person or organisation. If you simply disagree with the claim, you can start your own petition or contact the author.

Click the false sentences in the petition text.

Which passage exactly is hate speech? Click the sentences in the petition text.

Which passage exactly calls for violence? Click the sentences in the petition text.

Which passage exactly glorifies or incites terrorism? Click the sentences in the petition text.

Which passage exactly harasses or bullies someone? Click the sentences in the petition text.

Which passage exactly reveals private information? Click the sentences in the petition text.

Which passage exactly accuses someone of a crime? Click the sentences in the petition text.

Which passage exactly calls for the death penalty or torture? Click the sentences in the petition text.

Sentences next to each other are joined into one claim. Click a sentence again to remove it.

Gilead: Please ask Health Canada to approve Truvada for PrEP

We are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis (PrEP). If you agree, please sign our Open Letter to Gilead Sciences.

Ed Gudaitis, General Manager

Gilead Sciences Canada

6711 Mississauga Road, Suite 600

Mississauga, ON

L5N 2W3

April 28th, 2015

Dear Mr. Gudaitis:

On behalf of HIV prevention agencies, gay men’s health organizations and gay men in Canada, we are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis.

In December 2010 the New England Journal of Medicine published findings from the Gilead sponsored iPrEx trial examining the effectiveness of HIV pre-exposure prophylaxis (PrEP) in gay men and other men who have sex with men. The study ultimately showed that HIV was successfully prevented in over 90% of cases in men who were adherent to a daily dose of Truvada. Similar results were demonstrated in the subsequent PROUD trial from the UK and IPERGAY in France and Canada.

The advent of PrEP and its subsequent uptake by HIV-negative gay men, particularly in the United States, has been a welcome addition to the HIV prevention toolkit. Traditional interventions such as education, condoms, and treatment as prevention have been highly successful but they have failed to completely stem the tide of new infections. In 2011, the Public Health Agency of Canada estimated the HIV incidence rate for men who have sex with men was 71 times higher than other men. In 2013 approximately 1000 Canadian gay men were diagnosed with HIV. These account for 50% of new infections in the country. Most become infected by partners who themselves are newly infected and/or unaware of their sero-positive status. PrEP offers additional protection to HIV-negative men who may find themselves in these situations.

In July 2012 the FDA approved the use of Truvada for PrEP in the United States and the US Centre for Disease Control developed clinical practice guidelines for administration of PrEP in vulnerable populations. Yet access to Truvada for PrEP in Canada remains elusive. Currently, it is prescribed “off-label” and treatment is administered under a patchwork of monitoring with little or no regulation. We applaud Gilead’s support for PrEP in the United States and its recent announcement to seek approval in Australia but without formal approval in Canada it is not possible to establish publicly funded and regulated programs, or to evaluate cost effectiveness and safety. This leaves gay men and other vulnerable groups with limited access to a proven prevention tool. We find this policy inequitable and harmful to gay men’s health.

At Health Initiative for Men, we consider PrEP to be a safe and effective HIV prevention tool when it is prescribed and administered in a regulated environment. We believe that barriers to access should be minimized for gay men and other vulnerable populations. A formally approved indication for the use of Truvada in HIV pre-exposure prophylaxis is the first step to achieving this goal. We further intend to actively petition public health officials at all levels for comprehensive PrEP guidelines and for approval of publicly funded programs. If we are to be serious about stopping HIV in all populations, and particularly in gay men, we must make PrEP more easily accessible. To quote from Chris Beyrer at the Center for Public Health and Human Rights in a recent Lancet publication, ‘Pre-exposure prophylaxis works – it’s time to deliver’.

Board of Directors,

Health Initiative for Men

Signatories:

AIDS Committee of Toronto (ACT)

AIDS Vancouver

Canadian Association of Nurses in HIV/AIDS Care (CANAC)

CATIE

REZO: Santé et mieux-être des hommes gais et bisexuels

Vancouver Coastal Health Regional HIV Program

YouthCO HIV & Hep C Society

Click the false sentences in the petition text.

Which passage exactly is hate speech? Click the sentences in the petition text.

Which passage exactly reveals private information? Click the sentences in the petition text.

Which passage exactly is terrorist or extremist content? Click the sentences in the petition text.

Sentences next to each other are joined into one claim. Click a sentence again to remove it.

Gilead: Please ask Health Canada to approve Truvada for PrEP

We are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis (PrEP). If you agree, please sign our Open Letter to Gilead Sciences.

Ed Gudaitis, General Manager

Gilead Sciences Canada

6711 Mississauga Road, Suite 600

Mississauga, ON

L5N 2W3

April 28th, 2015

Dear Mr. Gudaitis:

On behalf of HIV prevention agencies, gay men’s health organizations and gay men in Canada, we are calling on Gilead Sciences to make immediate application to Health Canada for use of Truvada in HIV pre-exposure prophylaxis.

In December 2010 the New England Journal of Medicine published findings from the Gilead sponsored iPrEx trial examining the effectiveness of HIV pre-exposure prophylaxis (PrEP) in gay men and other men who have sex with men. The study ultimately showed that HIV was successfully prevented in over 90% of cases in men who were adherent to a daily dose of Truvada. Similar results were demonstrated in the subsequent PROUD trial from the UK and IPERGAY in France and Canada.

The advent of PrEP and its subsequent uptake by HIV-negative gay men, particularly in the United States, has been a welcome addition to the HIV prevention toolkit. Traditional interventions such as education, condoms, and treatment as prevention have been highly successful but they have failed to completely stem the tide of new infections. In 2011, the Public Health Agency of Canada estimated the HIV incidence rate for men who have sex with men was 71 times higher than other men. In 2013 approximately 1000 Canadian gay men were diagnosed with HIV. These account for 50% of new infections in the country. Most become infected by partners who themselves are newly infected and/or unaware of their sero-positive status. PrEP offers additional protection to HIV-negative men who may find themselves in these situations.

In July 2012 the FDA approved the use of Truvada for PrEP in the United States and the US Centre for Disease Control developed clinical practice guidelines for administration of PrEP in vulnerable populations. Yet access to Truvada for PrEP in Canada remains elusive. Currently, it is prescribed “off-label” and treatment is administered under a patchwork of monitoring with little or no regulation. We applaud Gilead’s support for PrEP in the United States and its recent announcement to seek approval in Australia but without formal approval in Canada it is not possible to establish publicly funded and regulated programs, or to evaluate cost effectiveness and safety. This leaves gay men and other vulnerable groups with limited access to a proven prevention tool. We find this policy inequitable and harmful to gay men’s health.

At Health Initiative for Men, we consider PrEP to be a safe and effective HIV prevention tool when it is prescribed and administered in a regulated environment. We believe that barriers to access should be minimized for gay men and other vulnerable populations. A formally approved indication for the use of Truvada in HIV pre-exposure prophylaxis is the first step to achieving this goal. We further intend to actively petition public health officials at all levels for comprehensive PrEP guidelines and for approval of publicly funded programs. If we are to be serious about stopping HIV in all populations, and particularly in gay men, we must make PrEP more easily accessible. To quote from Chris Beyrer at the Center for Public Health and Human Rights in a recent Lancet publication, ‘Pre-exposure prophylaxis works – it’s time to deliver’.

Board of Directors,

Health Initiative for Men

Signatories:

AIDS Committee of Toronto (ACT)

AIDS Vancouver

Canadian Association of Nurses in HIV/AIDS Care (CANAC)

CATIE

REZO: Santé et mieux-être des hommes gais et bisexuels

Vancouver Coastal Health Regional HIV Program

YouthCO HIV & Hep C Society

We use this to acknowledge your report and to tell you the outcome.
I am reporting
What are you asking for? You can choose more than one.
May we forward your request to the petition author? The author can remove the petition for any reason, and may respond to the request sooner than our moderators.
May we forward your request to the petition author? The author can remove the petition for any reason, and may respond to the request sooner than our moderators.
May we forward your request to the petition author? The author can remove the petition for any reason, and may respond to the request sooner than our moderators.

Reported petitions are reviewed by our team to determine if they violate our Terms of Service or Community Guidelines.